Frank D. Heuszel
CIK: 0001748704
Transaction Breakdown
Open Market Buys (P)4 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IBO
IMPACT BIOMEDICAL INC.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Dec 5, 2024IBO
IMPACT BIOMEDICAL INC.
Purchase(P)Direct500 shares at avg. $2.26$1K - Nov 27, 2024IBO
IMPACT BIOMEDICAL INC.
Purchase(P)Direct500 shares at avg. $2.61$1K - Nov 26, 2024IBO
IMPACT BIOMEDICAL INC.
Purchase(P)Direct550 shares at avg. $2.63$1K - Nov 26, 2024IBO
IMPACT BIOMEDICAL INC.
Purchase(P)Direct500 shares at avg. $2.59$1K
1-4 of 4 transactions
About Heuszel Frank D
Heuszel Frank D (SEC CIK 0001748704) files insider reports with the SEC as Chief Executive Officer of IMPACT BIOMEDICAL INC. (IBO).
Signal8 holds 4 ownership filings by Heuszel Frank D (1 Form 3, 3 Form 4), filed between Sep 16, 2024 and Dec 9, 2024. Those filings report 4 transactions, from Nov 26, 2024 to Dec 5, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Heuszel Frank D's filings is in HOUSTON, TX.
Recent filings by Heuszel Frank D
Other insiders filing for IMPACT BIOMEDICAL INC. (IBO)
- DSS, INC., 10% Owner
- Macko Todd D, Chief Financial Officer
- Grady Jason, Director
- Chan Heng Fai Ambrose, 10% Owner
- Keene David K, Director
- Brownell Elise, Director